Aspirin Use Is Associated With Improved Outcomes in Inflammatory Breast Cancer Patients

CONCLUSION: ASA use during remission was associated with significantly improved OS and DMFS in patients with IBC. These results suggest that ASA may provide survival benefits to patients with IBC. Prospective clinical trials of ASA use in patients with high-risk IBC in remission should be considered.PMID:36762783 | DOI:10.4048/jbc.2023.26.e3

Source: Journal of Breast Cancer - February 10, 2023 Category: Cancer & Oncology Authors: Christopher Johns Allen Yen Asal Rahimi Yu-Lun Liu Ann Marilyn Leitch Ann Spangler Prasanna Alluri Chika Nwachukwu Rachel Wooldridge Deborah Farr D W Nathan Kim Source Type: research